Contact STAAR® Surgical Company for Information on the Visian ICL™
The contact form below can be used to request additional information about the Visian ICL and STAAR Surgical Company. If you are an ophthalmologist or other medical professional interested in becoming certified in the Visian ICL vision correction, obtaining further information about how the phakic intraocular lens works, or learning more about what characteristics define a good Visian ICL patient, contact STAAR Surgical Company by completing the form below.
You can locate an ICL-trained ophthalmologist through this website's Find a Doctor page. To request additional information on the Visian ICL or STAAR Surgical Company, consumers can also use the form below.
Thank you for contacting STAAR Surgical Company. A member of our Customer Service department will respond to your request in a timely manner.
About STAAR Surgical Company
STAAR Surgical Company's corporate office and U.S. headquarters is located in Monrovia, California. The company also has a European headquarters in Switzerland and distributors throughout the world.
STAAR Surgical Company was founded in 1982 with the goal of creating and manufacturing the world's first foldable intraocular lens (IOL) for cataract surgery. As the company grew, it expanded its focus to include refractive surgery and glaucoma treatments.
STAAR Surgical Company's Visian ICL Journey
In 1993, STAAR Surgical Company began feasibility studies on a phakic IOL, referred to as an implantable contact lens. Three years later, the company began to market its ICL in selected countries. In 1997, the company's implantable contact lens received the CE Marking, which indicates that the product was approved by the European Union (EU). The EU represents 28 countries.
STAAR Surgical Company continued to complete the required trials in the United States and in 2005 received FDA approval for the Visian ICL. (At the FDA's request, STAAR Surgical Company markets the ICL as an implantable Collamer lens, rather than an implantable contact lens, in the United States.) There are three models of the Visian ICL (one to treat myopia or nearsightedness, one to treat myopia with astigmatism, and one to treat hyperopia, or farsightedness) available outside the United States, but currently only the myopic version has received FDA approval. The Visian Toric ICL™ (TICL) is under review with the U.S. FDA.
Trademark Information
STAAR and Collamer are registered trademarks of STAAR Surgical Company. Visian ICL, Visian TICL, and Visian Toric ICL are trademarks of STAAR Surgical Company.
Non-STAAR Trademark Information
Verisyse is a trademark of Advanced Medical Optics, Inc. IntraLase is a registered trademark of IntraLase Corp.
Terms of Service
STAAR Surgical Company values you as a customer and we respect your right to online privacy while using our website. Our Internet Policy is shared with you because we are committed to protecting your privacy while using our website.
Any information that you provide us will be maintained in the strictest confidence within our internal computer systems.
All of the information on this Website including the trademarks, service marks, brand identities, characters, trade names, graphics, designs, copyrights, trade dress, and all other intellectual property (“Content”) is protected intellectual property of STAAR Surgical Company with all rights reserved. This includes the entire Content of the Website(s) copyrighted and protected as a collective work. You may not copy, distribute, modify, transmit, reuse, re-post or otherwise display the Website(s) Content for public or commercial purposes without the written permission of STAAR Surgical Company.
Visian ICL Glossary
When researching Visian ICL, you may encounter unfamiliar terminology related to this and other products and procedures. For your convenience, the Visian ICL Glossary defines many of the ophthalmic terms used throughout this website.